Cancer Topics - Recent Approvals: Erdafitinib and Enfortumab for Second-Line Treatment of Metastatic Bladder Cancer
Feb 12, 2020
05:39
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Winston Tan, Medical Oncologist at Mayo Clinic, discusses the recent FDA approval of erdafitinib and enfortumab for second-line treatment of metastatic bladder cancer.
ASCO Education